Yin-Ling Zhang

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Fudan University Shanghai Cancer Center(Current)

Shanghai Medical College of Fudan University

Yin-Ling Zhang is an author at Fudan University Shanghai Cancer Center specializing in metastatic breast cancer, triple-negative breast cancer therapy, and cancer cell signaling.

ORCID

Publications per year

2022–2024

Publications

Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Li Liao, Yin-Ling Zhang, Ling Deng et al. · Cancer Research · 2022 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +16

Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A

Lisa Andriani, Yun-Xiao Ling, Shao‐Ying Yang et al. · Cancer Letters · 2024 · 13 citations

Life Sciences, Oncology, Pharmacology +15

1–2 of 2